Aclarion is a healthcare technology company. The first application of Co.'s technology is focused on improving surgical decision making when surgical intervention is being contemplated for patients with low back pain. Co.'s commercial product, NOCISCAN-LS, utilizes its proprietary biomarkers and algorithms to provide surgeons with information about which intervertebral discs are determined to be consistent with generating pain, and which are not. The main technology underlying NOCISCAN-LS is the use of Magnetic Resonance spectroscopy to identify the chemical makeup of intervertebral discs with a focus on identifying specific proprietary biomarkers. We show 5 historical shares outstanding datapoints in our ACON shares outstanding history coverage, used to compute ACON market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ACON market cap history over the course of time is important for investors
interested in comparing ACON's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ACON versus a peer is one thing; comparing
ACON market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ACON can fluctuate over the course of history.
With this page we aim to empower investors researching ACON by allowing them to research the ACON market cap history. |
Free ACON Email Alerts:
Video: The Importance of Market Cap
